Alphabet Inc. - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Alphabet Inc. ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$1,626,950
-2.1%
698,2620.0%0.10%
+16.9%
Q2 2023$1,661,863
+29.3%
698,2620.0%0.09%
+25.4%
Q1 2023$1,284,802
-3.2%
698,2620.0%0.07%
-7.8%
Q4 2022$1,326,698
-11.2%
698,2620.0%0.08%
+1.3%
Q3 2022$1,494,000
-24.4%
698,2620.0%0.08%
-29.0%
Q2 2022$1,976,000
-32.1%
698,2620.0%0.11%
+13.8%
Q1 2022$2,912,000
-19.6%
698,2620.0%0.09%
+6.8%
Q4 2021$3,624,000
-20.8%
698,2620.0%0.09%
-19.3%
Q3 2021$4,574,000
-1.3%
698,2620.0%0.11%
+16.0%
Q2 2021$4,636,000
+15.9%
698,2620.0%0.09%
-41.6%
Q1 2021$4,001,000
-35.9%
698,2620.0%0.16%
-46.2%
Q4 2020$6,242,000
-23.2%
698,2620.0%0.30%
-21.7%
Q3 2020$8,128,000
-27.4%
698,2620.0%0.38%
-26.1%
Q2 2020$11,193,000
+167.2%
698,262
-0.2%
0.52%
+88.0%
Q1 2020$4,189,000
-54.6%
699,3520.0%0.28%
-50.7%
Q4 2019$9,231,000
+6.3%
699,3520.0%0.56%
+113.8%
Q3 2019$8,686,000
-22.9%
699,3520.0%0.26%
+22.0%
Q2 2019$11,260,000
-49.9%
699,352
-2.1%
0.21%
-81.6%
Q1 2019$22,472,000
-4.2%
714,0720.0%1.16%
-58.1%
Q4 2018$23,450,000
+7.1%
714,0720.0%2.77%
+32.2%
Q3 2018$21,901,000
+14.5%
714,0720.0%2.10%
+30.6%
Q2 2018$19,130,000714,0721.61%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$49,738,11274.10%
TFG Asset Management GP Ltd 12,000,000$27,960,0005.10%
Paradigm Biocapital Advisors LP 14,406,782$33,567,8022.28%
Lynx1 Capital Management LP 1,363,025$3,175,8482.10%
Deep Track Capital, LP 15,000,000$34,950,0001.35%
Affinity Asset Advisors, LLC 1,992,466$4,642,4461.31%
DAFNA Capital Management LLC 928,253$2,162,8290.67%
Frazier Life Sciences Management, L.P. 3,746,857$8,730,1770.58%
ARMISTICE CAPITAL, LLC 6,900,000$16,077,0000.25%
Blackstone Inc. 20,485,611$47,731,4740.20%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders